ACTRN12617000731392已完成1 期
The effect of 1,3-butanediol on immunity and tolerability in recreationally active, healthy males at rest.
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 35 Years（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
The effect of a dietary ketone on immunity, tolerability and performance in well-trained, healthy male cyclists.Exercise-Induced immunosuppressionGastrointestinal distressSystemic symptoms (e.g. dizziness, nausea)Inflammatory and Immune System - Other inflammatory or immune system disordersOral and Gastrointestinal - Normal oral and gastrointestinal development and functionOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12617001347358Auckland University of Technology9
已完成
不适用
Humoral and T-cell responses to a third dose of BNT162b2 and mRNA-1273 COVID-19 Vaccine in Patients with hematological diseases treated with rituximab or obinutuzumab: An observational study.Hematological diseasesJPRN-UMIN000046603Kobe City Medical Center General Hospital, Department of Hematology68
已完成
不适用
Immunological effects of BCG on vaccination with the yellow fever vaccine.Immune modulationmodulation of the immune system10002252NL-OMON40902niversitair Medisch Centrum Sint Radboud30
尚未招募
3 期
Immunogenicity and safety after vaccinated with BBIBP-CorV (COVID-19 vaccine) in Thai pregnant womePregnant womenCOVID-19SARS-CoV-2 vaccineVaccinePregnantBBIBP-CorVSinopharmTCTR20210923013Chulabhorn Hospital400
进行中（未招募）
不适用
Evaluation of the immune response and safety of a booster dose of Pfizer's13-valent pneumococcal conjugate vaccine in children primed with 2 dosesof either GSK's 10-valent pneumococcal conjugate vaccine or Pfizer's 13-valent pneumococcal conjugate vaccine in the Slovak RepublicTo induce appropriate protection against pneumococcal disease. Toassess non-inferiority of OPA response for serotype 19A after boosterdose of PCV13 administered between 11-12 months of age in subjectsprimed with 10Pn-PD-DiT vs those primed with PCV13.EUCTR2012-005367-27-SKBIOVOMED